Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen CorporationfiledCriticalNeurogen Corporation
Priority to YU35292ApriorityCriticalpatent/YU35292A/en
Publication of YU35292ApublicationCriticalpatent/YU35292A/en
IZVESNI IMIDAZOHINOKSALINI NOVA KLASA GABA MOŽDANIH RECEPTORSKIH LIGANADA, ovaj pronalazak obuhvata jedinjenja formule: i farmaceutski prihvatljive njihove netoksične soli, gde R1, R2, R3, R4, X I W su promenljivi. Ova jedinjenja su visoko selektivni agonisti, antagonisti ili inverzni agonisti za GABAs moždane receptore ili njihove prolekove i korisna su u dijagnozi i tretiranju poremećaja sna, nesanice uznemirenosti, predoziranja sa benzodiazepinskim lekovima i pojačanju memorije.CERTAIN IMIDAZOCHINOXALINES A NEW CLASS OF GABA OF BRAIN RECEPTOR LIGANADES, the present invention encompasses compounds of the formula: and pharmaceutically acceptable non-toxic salts thereof, wherein R 1, R 2, R 3, R 4, X and W are variable. These compounds are highly selective agonists, antagonists or inverse agonists for GABAs brain receptors or their prodrugs and are useful in the diagnosis and treatment of sleep disorders, insomnia, anxiety, benzodiazepine drug overdoses and memory enhancement.
YU35292A1992-04-031992-04-03
CERTAIN IMIDAZOCHINOXALINES A NEW CLASS OF GABA OF BRAIN RECEPTOR LIGANDS
YU35292A
(en)